Premenstrual Dysphoric Disorder Awareness and Research Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 30
- Latest action
- Mar 30, 2026
What it does
The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 would expand research, improve awareness, and increase access to treatment for individuals affected by PMDD, a severe condition impacting an estimated 5 to 8 percent of women and people assigned female at birth of reproductive age. The bill directs the Secretary of Health and Human Services to intensify NIH research on PMDD causes, diagnosis, and treatment; collect and publish data on prevalence, economic impact, and barriers to care; launch public and provider awareness campaigns; develop continuing medical education materials; award grants to train health professionals; and submit a progress report to Congress within…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
- Yassamin Ansari
- Adelita Grijalva
- April McClain Delaney
- Ayanna Pressley
- Dan Goldman
- Deborah Ross
- Eleanor Norton
- Frederica Wilson
- Henry Johnson
- Herbert Conaway
- Jonathan Jackson
- Joyce Beatty
- Julia Brownley
- Lauren Underwood
- Lizzie Fletcher
- Lori Trahan
- Morgan McGarvey
- Nikema Williams
- Nydia Velázquez
- Paul Tonko
- Pramila Jayapal
- Raja Krishnamoorthi
- Rashida Tlaib
- Sarah McBride
- Shri Thanedar
- Suzanne Bonamici
- Timothy Kennedy
- Troy Carter
- Wesley Bell
- Yvette Clarke
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.